Adrenal suppression from vamorolone and prednisone in Duchenne muscular dystrophy: results from the phase 2b clinical trial.
Alexandra AhmetRebecca TobinUtkarsh J DangRaoul RoomanMichela GuglieriPaula R ClemensEric P HoffmanLeanne M WardPublished in: The Journal of clinical endocrinology and metabolism (2024)
AS after vamorolone and prednisone was frequent and vamorolone-associated AS appeared dose-dependent. A lower stimulated cortisol threshold may be appropriate when using a monoclonal assay. We recommend hydrocortisone for glucocorticoid stress dosing in patients receiving vamorolone.